PhotoMedex Inc (PHMD)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PhotoMedex Inc (PHMD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014218
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PhotoMedex Inc (PhotoMedex) is a medical device company that provides dermatological solutions. The company offers Neova, Tricomin and IAMIN products. Its products are used in the treatment of skin diseases and conditions such as psoriasis, vitiligo, acne, actinic keratosis. PhotoMedex provides scientific development and has led to a broad range of FDA clearances. The company provides Copper Peptide technology for skin health, hair care and wound care. Its Neova products are used in therapeutic skin care and LED therapy for acne and photodamage. The company caters to dermatologists, professional aestheticians and consumers in the US. PhotoMedex is headquartered in Willow Grove, Pennsylvania, the US.

PhotoMedex Inc (PHMD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PhotoMedex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PhotoMedex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PhotoMedex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PhotoMedex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PhotoMedex Inc, Medical Devices Deals, 2011 to YTD 2017 9
PhotoMedex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PhotoMedex Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
PhotoMedex Extends Distribution Agreement With Ya-Man 11
Equity Offering 12
PhotoMedex Completes Public Offering Of Common Stock For US$27.6 Million 12
PhotoMedex Completes Private Placement Of Shares For US$12.4 Million 14
Acquisition 15
Vision Acquisition Acquires LCA-Vision from PhotoMedex for USD40 Million 15
PhotoMedex Acquires LCA-Vision for USD106.4 Million 16
PhotoMedex Inc – Key Competitors 18
PhotoMedex Inc – Key Employees 19
PhotoMedex Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Mar 09, 2016: PhotoMedex Transfers U.S. Listing to NASDAQ Capital Market 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
PhotoMedex Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
PhotoMedex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PhotoMedex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PhotoMedex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PhotoMedex Inc, Deals By Therapy Area, 2011 to YTD 2017 8
PhotoMedex Inc, Medical Devices Deals, 2011 to YTD 2017 9
PhotoMedex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PhotoMedex Extends Distribution Agreement With Ya-Man 11
PhotoMedex Completes Public Offering Of Common Stock For US$27.6 Million 12
PhotoMedex Completes Private Placement Of Shares For US$12.4 Million 14
Vision Acquisition Acquires LCA-Vision from PhotoMedex for USD40 Million 15
PhotoMedex Acquires LCA-Vision for USD106.4 Million 16
PhotoMedex Inc, Key Competitors 18
PhotoMedex Inc, Key Employees 19
PhotoMedex Inc, Subsidiaries 20

★海外企業調査レポート[PhotoMedex Inc (PHMD)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arthrex Inc-医療機器分野:企業M&A・提携分析
    Summary Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company which designs, and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and …
  • JSS Medical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary JSS Medical Research Inc (JSS) is a contract research organization which offers clinical research services. It provides clinical trial services in various therapeutic areas that include cardiovascular disorders, oncology, infectious disease, neurology and psychiatry, autoimmune disorders, re …
  • Bio-Path Holdings Inc (BPTH):企業の財務・戦略的SWOT分析
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析
    Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Paranta Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Paranta Biosciences Ltd (Paranta Biosciences) is a biopharmaceutical company that develops bio-therapeutics for the treatment of inflammatory and fibrotic diseases. The company develops product candidate PB01, a recombinant human follistatin-288 used for the treatment of cystic fibrosis lung …
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Workday, Inc.:企業のM&A・事業提携・投資動向
    Workday, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Workday, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • ImevaX GmbH-製薬・医療分野:企業M&A・提携分析
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops specific vaccines against chronic infections. The company identifies and uses immune modulatory bacterial factors to develop specific vaccines. It develops specific vaccines against pathogens that cause chronic infectious dise …
  • Composites Technology Research Malaysia Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Virgin Active Limited:企業の戦略・SWOT・財務分析
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company that discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company provides product portfolio such as encompasses investigational candidates in preclinical trials: peptide-sm …
  • Advantest Corporation:企業の戦略・SWOT・財務情報
    Advantest Corporation - Strategy, SWOT and Corporate Finance Report Summary Advantest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lumosa Therapeutics Co Ltd (6535):製薬・医療:M&Aディール及び事業提携情報
    Summary Lumosa Therapeutics Co Ltd (Lumosa Therapeutics) is a developer of drugs for the treatment of neurological and inflammatory diseases. The company’s pipeline products include LT-1001, an analgesic injection for severe pain relief; and LT-3001, a novel small molecule for acute ischemic stroke. …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nice-Pak Products, Inc.:企業の戦略・SWOT・財務情報
    Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Jardine Cycle & Carriage Ltd (C07):企業の財務・戦略的SWOT分析
    Jardine Cycle & Carriage Ltd (C07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rio Tinto:企業のM&A・事業提携・投資動向
    Rio Tinto - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rio Tinto Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆